Literature DB >> 15878506

Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.

Hsin-Ell Wang1, Shih-Yen Wu, Chi-Wei Chang, Ren-Shen Liu, Li-Chung Hwang, Te-Wei Lee, Jyh-Cheng Chen, Jeng-Jong Hwang.   

Abstract

UNLABELLED: 2-Deoxy-2-[(18)F]fluoro-d-glucose ([(18)F]FDG) has been extensively used as positron emission tomography (PET) tracer in clinical tumor imaging. This study compared the pharmacokinetics of two (18)F-labeled amino acid derivatives, O-2-[(18)F]fluoroethyl-l-tyrosine (l-[(18)F]FET) and 4-borono-2-[(18)F]fluoro-l-phenylalanine-fructose (l-[(18)F]FBPA-Fr), to that of [(18)F]FDG in an animal brain tumor model.
METHODS: A self-modified automated PET tracer synthesizer was used to produce no-carrier-added (nca) l-[(18)F]FET. The cellular uptake, biodistribution, autoradiography and microPET imaging of l-[(18)F]FET, l-[(18)F]FBPA-Fr and [(18)F]FDG were performed with F98 glioma cell culture and F98 glioma-bearing Fischer344 rats.
RESULTS: The radiochemical purity of l-[(18)F]FET was >98% and the radiochemical yield was 50% in average of 16 runs. The uptake of l-[(18)F]FET and l-[(18)F]FBPA-Fr in the F98 glioma cells increased rapidly for the first 5 min and reached a steady-state level after 10 min of incubation, whereas the cellular uptake of [(18)F]FDG kept increasing during the study period. The biodistribution of l-[(18)F]FET, l-[(18)F]FBPA-Fr and [(18)F]FDG in the brain tumors was 1.26+/-0.22, 0.86+/-0.08 and 2.77+/-0.44 %ID/g at 60 min postinjection, respectively, while the tumor-to-normal brain ratios of l-[(18)F]FET (3.15) and l-[(18)F]FBPA-Fr (3.44) were higher than that of [(18)F]FDG (1.44). Both microPET images and autoradiograms of l-[(18)F]FET and l-[(18)F]FBPA-Fr exhibited remarkable uptake with high contrast in the brain tumor, whereas [(18)F]FDG showed high uptake in the normal brain and gave blurred brain tumor images.
CONCLUSION: Both l-[(18)F]FET and l-[(18)F]FBPA-Fr are superior to [(18)F]FDG for the brain tumor imaging as shown in this study with microPET.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15878506     DOI: 10.1016/j.nucmedbio.2005.01.005

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  9 in total

Review 1.  Current trends in the surgical management and treatment of adult glioblastoma.

Authors:  Richard M Young; Aria Jamshidi; Gregory Davis; Jonathan H Sherman
Journal:  Ann Transl Med       Date:  2015-06

2.  Comparison of [18F]-tracers in various experimental tumor models by PET imaging and identification of an early response biomarker for the novel microtubule stabilizer patupilone.

Authors:  T Ebenhan; M Honer; S M Ametamey; P A Schubiger; M Becquet; S Ferretti; C Cannet; M Rausch; P M J McSheehy
Journal:  Mol Imaging Biol       Date:  2009-05-22       Impact factor: 3.488

3.  One-step synthesis of an 18F-labeled boron-derived methionine analog: a substitute for 11C-methionine?

Authors:  Zhen Liu; Emily B Ehlerding; Weibo Cai; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-01-18       Impact factor: 9.236

4.  Targeting glioblastoma using a novel peptide specific to a deglycosylated isoform of brevican.

Authors:  Niklas von Spreckelsen; Colin M Fadzen; Nina Hartrampf; Yarah Ghotmi; Justin M Wolfe; Shipra Dubey; Bo Yeun Yang; Marie F Kijewski; Shuyan Wang; Charlotte Farquhar; Sonja Bergmann; Mykola Zdioruk; J Roscoe Wasserburg; Benjamin Scott; Emily Murrell; Fernanda C Bononi; Leonard G Luyt; Marcelo DiCarli; Martine L M Lamfers; Keith L Ligon; E Antonio Chiocca; Mariano S Viapiano; Bradley L Pentelute; Sean E Lawler; Choi-Fong Cho
Journal:  Adv Ther (Weinh)       Date:  2021-01-20

5.  (18)F-FET and (18)F-FCH uptake in human glioblastoma T98G cell lines.

Authors:  Marco Giovanni Persico; Federica Eleonora Buroni; Francesca Pasi; Lorenzo Lodola; Carlo Aprile; Rosanna Nano; Marina Hodolic
Journal:  Radiol Oncol       Date:  2016-04-19       Impact factor: 2.991

6.  18F-fluoro-ethyl-tyrosine (18F-FET) PET/CT as a potential new diagnostic tool in multiple myeloma: a preliminary study.

Authors:  Jarosław Czyż; Bogdan Małkowski; Artur Jurczyszyn; Norbert Grząśko; Rita Łopatto; Monika Olejniczak; Adriana Czyż; Anna Jachalska
Journal:  Contemp Oncol (Pozn)       Date:  2019-03-04

7.  The use of longitudinal 18F-FET MicroPET imaging to evaluate response to irinotecan in orthotopic human glioblastoma multiforme xenografts.

Authors:  Mette K Nedergaard; Karina Kristoffersen; Signe R Michaelsen; Jacob Madsen; Hans S Poulsen; Marie-Thérése Stockhausen; Ulrik Lassen; Andreas Kjaer
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

8.  Evaluation of D-isomers of 4-borono-2-18F-fluoro-phenylalanine and O-11C-methyl-tyrosine as brain tumor imaging agents: a comparative PET study with their L-isomers in rat brain glioma.

Authors:  Masakatsu Kanazawa; Shingo Nishiyama; Fumio Hashimoto; Takeharu Kakiuchi; Hideo Tsukada
Journal:  EJNMMI Res       Date:  2018-06-13       Impact factor: 3.138

9.  [18F]Fluoro-DCP, a first generation PET radiotracer for monitoring protein sulfenylation in vivo.

Authors:  Kiran Kumar Solingapuram Sai; Xiaofei Chen; Zhe Li; Caigang Zhu; Kirtikar Shukla; Tom E Forshaw; Hanzhi Wu; Stephen A Vance; Buddhika Liyana Pathirannahel; Megan Madonna; Mark W Dewhirst; Allen W Tsang; Leslie B Poole; Nimmi Ramanujam; S Bruce King; Cristina M Furdui
Journal:  Redox Biol       Date:  2021-12-18       Impact factor: 11.799

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.